`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`V.
`
`QUALICAPS CO., LTD,
`Patent Owner
`
`Case IPR2017-00203
`Patent 6,649,180
`
`DECLARATION OF MEGAN P. KEANE IN SUPPORT OF
`PATENT OWNER'S MOTION FOR ADMISSION PRO HAC VICE OF
`MEGAN P. KEANE UNDER 37 C.F.R. § 42.10
`
`Mylan v. Qualicaps, IPR2017-00203
`QUALICAPS EX. 2026 - 1/4
`
`
`
`IPR2017-00203
`
`I, Megan P. Keane, declare as follows:
`
`1.
`
`I am an associate in the law firm Covington & Burling LLP.
`
`2.
`
`I am a member in good standing of the Pennsylvania State Bar
`
`(admitted 2009) and the District of Columbia Bar (2010), as well as the following
`
`federal Courts: U.S. District Court for the District of Columbia (2012) and the
`
`U.S. Court of Appeals for the Federal Circuit (2016).
`
`3.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`4.
`
`I have never had an application for admission to practice before any
`
`court or administrative body denied.
`
`5.
`
`I have had no sanctions or contempt citations imposed against me by
`
`any court or administrative body.
`
`6.
`
`I have read and will comply with the Office Patent Trial Guide and
`
`the Board's Rules for Practice for Trials set forth in part 42 of the Code of Federal
`
`Regulations.
`
`7.
`
`I agree to be subject to the USPTO Rules of Professional Conduct set
`
`forth in 37 C.F.R. §§ 11.101 et seq. and disciplinary jurisdiction under 37 C.F.R.
`
`§ 11.19(a).
`
`Mylan v. Qualicaps, IPR2017-00203
`QUALICAPS EX. 2026 - 2/4
`
`
`
`IPR2017-00203
`
`8.
`
`I have previously applied to appear pro hac vice in one proceeding
`
`before the Office, on behalf of Eli Lilly and Company in IPR2016-00458. The pro
`
`hac vice motion was granted by the Office.
`
`9.
`
`I am an experienced litigating attorney with over seven years in
`
`private law practice, including experience with bench trials, jury trials, and
`
`Markman hearings. I have been counsel in over twenty patent infringement cases,
`
`including cases pending in various district courts.
`
`10. I am familiar with the subject matter and U.S. Patent No. 6,649,180
`
`("the 'ISO Patent") at issue in this proceeding, including its prosecution history and
`
`the scientific field to which the '180 Patent is addressed. In particular, I am
`
`advising the Patent Owner regarding the Patent Owner's Response to the Petition,
`
`and have thereby developed a thorough understanding of the '180 Patent, the
`
`relevant art, and scientific field. In addition, I am or have been counsel of record
`
`in patent infringement cases involving pharmaceutical formulation patents. These
`
`activities have required developing a thorough understanding of the patent at issue
`
`in this proceeding, the prior art, and the relevant scientific field.
`
`11. I also have extensive experience litigating and advising clients
`
`relating to pharmaceutical patents. Specifically, I have experience working with
`
`experts and developing strategy in proceedings before the Patent Trial and Appeal
`
`Board relating to other pharmaceutical products. In addition, I have been counsel
`
`Mylan v. Qualicaps, IPR2017-00203
`QUALICAPS EX. 2026 - 3/4
`
`
`
`IPR2017-00203
`
`of record in over fifteen district court cases in which pharmaceutical patents were
`
`at issue.
`
`12. I hereby declare that all statements made herein of my own
`
`knowledge are true and that all statements made on information and belief are
`
`believed to be true; and further that these statements are made with the knowledge
`
`that willful false statements and the like so made are punishable by fine or
`
`imprisonment, or both, under Section 1001 of Title 18 of the United States Code.
`
`Dated: 5" / / f?
`
`By
`
`Mega^P. Keane
`Covington & Burling LLP
`One CityCenter
`850 Tenth Street, NW
`Washington, DC 20001
`(202) 662-6000
`
`Mylan v. Qualicaps, IPR2017-00203
`QUALICAPS EX. 2026 - 4/4
`
`